Litcius/Paper detail

Cardiac Myosin Activator Omecamtiv Mecarbil Improves Left Ventricular Myocardial Deformation in Chronic Heart Failure

Tor Biering‐Sørensen, Masatoshi Minamisawa, Brian Claggett, Jiankang Liu, G. Michael Felker, John J.V. McMurray, Fady I. Malik, Siddique Abbasi, Christopher E. Kurtz, John R. Teerlink, Scott D. Solomon

2020Circulation Heart Failure14 citationsDOI

Topics & Concepts

MedicineHeart failureCardiologyInternal medicineCardiovascular Function and Risk FactorsCardiac pacing and defibrillation studiesCardiomyopathy and Myosin Studies
Cardiac Myosin Activator Omecamtiv Mecarbil Improves Left Ventricular Myocardial Deformation in Chronic Heart Failure | Litcius